Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches

Cardiovasc Drugs Ther. 2025 Dec;39(6):1521-1548. doi: 10.1007/s10557-024-07642-5. Epub 2024 Dec 6.

Abstract

Objective: Cardiovascular diseases (CVDs) are major public health problems that threaten the lives and health of individuals. The article has reviewed recent progresses about ferroptosis and ferroptosis-related intervention approaches for the treatment of CVDs and provided more references and strategies for targeting ferroptosis to prevent and treat CVDs.

Methods: A comprehensive review was conducted using the literature researches.

Results and discussion: Many ferroptosis-targeted compounds and ferroptosis-related genes may be prospective targets for treating CVDs and our review provides a solid foundation for further studies about the detailed pathological mechanisms of CVDs.

Conclusion: There are challenges and limitations about the translation of ferroptosis-targeted potential therapies from experimental research to clinical practice. It warrants further exploration to pursure safer and more effective ferroptosis-targeted thereapeutic approaches for CVDs.

Keywords: Amino acid metabolism; Cardiovascular diseases; Ferroptosis; Iron metabolism; Lipid metabolism.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Agents* / adverse effects
  • Cardiovascular Agents* / pharmacology
  • Cardiovascular Agents* / therapeutic use
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / pathology
  • Ferroptosis* / drug effects
  • Ferroptosis* / genetics
  • Humans
  • Molecular Targeted Therapy
  • Signal Transduction / drug effects

Substances

  • Cardiovascular Agents